-
Company Insights
Sanofi S.A – Digital Transformation Strategies
Sanofi Digital Transformation Strategies Report Overview Sanofi S.A. (Sanofi) has been focusing on using artificial intelligence, cloud, virtual reality and big data to digitally transform its operations. The annual ICT spending of Sanofi was estimated at $1.1 billion for 2023. A major share of this spending is earmarked for acquiring software, ICT services and consulting services from vendors. Sanofi is a France-based multinational life sciences company. It focuses on the research & development, manufacture, and marketing of a wide range...
-
Sector Analysis
Digital Biomarkers Market Size, Share and Trends Analysis by Region, Product Type (Wearable Application, Mobile Application, Portables), End-user (Healthcare Companies and Services, Others), and Segment Forecast, 2022-2027
The digital biomarkers market size was valued at US$2.32 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 25.7% during 2022-2027. The key to the digital biomarkers market growth has been the aging population and rise in chronic diseases, increasing investments and funding to develop digital biomarkers, and increasing role of digital biomarkers in clinical trials. Additionally, key strategic partnerships and mergers and acquisitions are expected to accelerate market growth. Over the forecast...
-
Thematic Analysis
Digital Therapeutics and their Impact on Healthcare
Due to increasing levels in healthcare spending combined with declining R&D returns, digital therapeutics (DTx) represent a new way of treatment in which digital systems are used as regulatory‐approved, to treat medical conditions as prescribed therapeutic interventions. There is a growing number of DTx developed on the market today as well as pipeline products in development following internationally-recognized, quality, design and manufacturing standards. DTx will provide a new approach to treatment and disease management in which patients have the possibility...